GlassScriptPhysician profile
Lior Michael Hirsch
NPI 1508251869
$7,895.25
in general payments reported to CMS, 2019-2025
44 companies · $1,604 in 2025
The $1,604 reported for 2025 was more than what 75% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,400 · 2020: $555 · 2021: $791 · 2022: $467 · 2023: $1,142 · 2024: $1,936 · 2025: $1,604.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,647 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,646.90 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $804.18 | 2020-2025 | Provenge |
| Medtronic, INC. | $798.05 | 2022-2025 | Interstim, Signia |
| Medical Device Business Services, INC. | $679.98 | 2019-2020 | |
| Medtronic USA, INC. | $597.99 | 2019 | |
| Janssen Biotech, INC. | $585.60 | 2021-2025 | Erleada, Akeega |
| Astellas Pharma US INC | $546.21 | 2020-2024 | Xtandi, Myrbetriq |
| Pfizer INC. | $343.44 | 2021-2025 | |
| Boston Scientific Corporation | $303.56 | 2019-2024 | Lithovue, Ams 700 |
| Abbvie INC. | $301.33 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $256.08 | 2024-2025 | Gemtesa, Orgovyx |
| Procept Biorobotics Corporation | $223.53 | 2024-2025 | Aquabeam System |
| Merck Sharp & Dohme LLC | $211.82 | 2021-2024 | Keytruda, Lynparza, Welireg |
| Tolmar, INC. | $205.63 | 2023-2025 | Eligard, Jatenzo |
| Axonics, INC. | $197.36 | 2022-2023 | Bulkamid, Axonics |
| Neotract INC. | $182.49 | 2019-2020 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lior Hirsch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.